Additionally, LACC1 diminishes the aggregation of inflammatory cells within the synovium of JIA patients and inhibits the degradation of the extracellular matrix in synovial fibroblasts by targeting the CCL5/CCR5 axis, thereby lessening joint damage (39). Here, LACC1 is linked to juvenile idiopathic arthritis.